Katana VentraIP

Drug liberalization

Drug liberalization is a drug policy process of decriminalizing, legalizing, or repealing laws that prohibit the production, possession, sale, or use of prohibited drugs. Variations of drug liberalization include drug legalization, drug relegalization, and drug decriminalization.[1] Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

Proponents of drug liberalization argue that the legalization of drugs would eradicate the illegal drug market and reduce the law enforcement costs and incarceration rates.[2] They frequently argue that prohibition of recreational drugs—such as cannabis, opioids, cocaine, amphetamines and hallucinogens—has been ineffective and counterproductive and that substance use is better responded to by implementing practices for harm reduction and increasing the availability of addiction treatment. Additionally, they argue that relative harm should be taken into account in the regulation of drugs. For instance, they may argue that addictive or dependence-forming substances such as alcohol, tobacco and caffeine have been a traditional part of many cultures for centuries and remain legal in most countries, although other drugs which cause less harm than alcohol, caffeine or tobacco are entirely prohibited, with possession punishable with severe criminal penalties.[3][4][5]


Opponents of drug liberalization argue that it would increase the amount of drug users, increase crime, destroy families, and increase the amount of adverse physical effects among drug users.[6]

with dosage and medical warnings.

Mandated labels

.

Restrictions on advertising

Age limitations.

Restrictions on amount purchased at one time.

Requirements on the form in which certain drugs would be supplied.

Ban on sale to intoxicated persons.

Special user licenses to purchase particular drugs.

A possible clinical setting for the consumption of some intravenous drugs and/or supervised consumption.

15 grams (or five plants)

Marijuana

5 grams

Hashish

40 pieces

Magic mushrooms

5 plants

Peyote

5 tablets

LSD

4 tablets

Ecstasy

2 grams

Amphetamine

2 grams

Methamphetamine

1.5 grams

Heroin

5 plants

Coca

1 gram

Cocaine

Groups advocating change[edit]

The Senlis Council, a European development and policy think tank, has, since its conception in 2002, advocated that drug addiction should be viewed as a public health issue rather than a purely criminal matter. The group does not support the decriminalisation of illegal drugs. Since 2003, the council has called for the licensing of poppy cultivation in Afghanistan in order to manufacture poppy-based medicines, such as morphine and codeine, and to combat poverty in rural communities, breaking ties with the illicit drugs trade. The Senlis Council outlined proposals for the implementation of a village based poppy for medicine project and calls for a pilot project for Afghan morphine at the next planting season.[148]

Le Dain Commission of Inquiry into the Non-Medical Use of Drugs

[157][158]

Australian Greens

[159]

Drug Law Reform Australia

[160]

Fusion Party

[161]

Legalise Cannabis Australia

Legalise Cannabis Queensland

Legalise Cannabis Western Australia Party

[162][163]

Reason Party

Anderson, D. Mark, and Daniel I. Rees. 2023. "." Journal of Economic Literature 61(1): 86–143.

The Public Health Effects of Legalizing Marijuana

International Coalition on Drug Policy Reform and Environmental Justice. 2023. "."

Revealing the missing link to Climate Justice: Drug Policy

– A UK-based think-tank that works to develop systems for control and regulation that can be applied globally.

Transform Drug Policy Foundation

– Run by retired law enforcement professionals who oppose prohibition.

Law Enforcement Against Prohibition

– a New York-based network of judges and lawyers opposed to current federal drug laws.

Voluntary Committee of Lawyers

– a US wide network of activists seeking to liberalize cannabis legislation.

NORML (US National Organization for the Reform of Marijuana Laws)

– an organisation for young people aged 16–25 campaigning against prohibition.

Re:Vision Drug Policy Network

– The LeDain Commission Report

The Report of the Canadian Government Commission of Inquiry into the Non-Medical Use of Drugs – 1972

– a project of the Transnational Institute (TNI)

Drug Law Reform

– an example of a policy formulation proposed for substance legalization

Draft Plan for Legalization from LIFE

Count The Costs

Schaffer Library of Drug Policy

Worldwide Psychedelic Laws Tracker